London, United Kingdom

Krishna Kolluri

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ucl Business Plc. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishna Kolluri. Retrieved from https://idiyas.com/inventor/krishna-kolluri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Krishna Kolluri in Cancer Research

Introduction

Krishna Kolluri is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly through his innovative work on biomarkers related to cell death in cancer cells. His research aims to improve the identification and treatment of cancer, showcasing his commitment to advancing medical science.

Latest Patents

Kolluri holds a patent for a cell death biomarker. This invention relates to the identification of cancer cells that are sensitive to death receptor ligand (DRL)-induced cell death. The patent also encompasses prognostic methods and kits designed to identify these sensitive cancer cells. Furthermore, it includes novel compositions and therapeutic methods that utilize these compositions for treating cancer.

Career Highlights

Krishna Kolluri is associated with UCL Business Plc, where he continues to develop his research and innovations. His work has the potential to significantly impact cancer treatment and patient outcomes. With a focus on practical applications of his research, Kolluri is dedicated to translating scientific discoveries into real-world solutions.

Collaborations

Some of his notable coworkers include Samuel Janes and Neelam Kumar. Their collaborative efforts contribute to the advancement of research in cancer therapies and biomarker development.

Conclusion

Krishna Kolluri's innovative work in cancer research, particularly through his patented biomarker, represents a significant step forward in the fight against cancer. His contributions are poised to enhance the understanding and treatment of this complex disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…